BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » Adipose SCs » Page 3

Okyanos – Adipose-Derived Stem Cell Treatments with CEO Matt Feshbach

By 1 Comment

Matthew Feshbach, CEO and Co-Founder of Okyanos
Matthew Feshbach, CEO and Co-Founder of Okyanos

Founded in 2011, Okyanos (pronounced “Oh – key – AH – nos”) is an innovative stem cell therapy provider that specializes in treating patients with congestive heart failure (CHF) and other chronic conditions. The literary name Okyanos, the Greek God of the river Okyanos, symbolizes the restoration of blood flow. Okyanos Cell Therapy delivers a mixed population of fat (adipose) derived stem and regenerative cells (ADRCs) using internationally-approved technology to patients with chronic, degenerative conditions.  Okyanos is fully licensed under the Bahamas Stem Cell Therapy and Research Act and adheres to U.S. surgical center standards.  [Read more…]

Current Landscape for Stem Cell Clinical Trials

By Leave a Comment

To understand the growing market potential for stem cell therapies, it is critical to consider the current landscape for stem cell clinical trials.

ClinicalTrials.govThere are 5561 clinical trials found when the term “stem cells” is searched on ClinicalTrials.gov, indicating that there are now thousands of stem cell trials underway worldwide. (Search executed November 7, 2016.)

ClinicalTrials.gov is the global registry of publicly and privately supported clinical studies involving human patients. While not a comprehensive resource, it contains approximately three-quarters of registered cell therapy trials worldwide.

Below is a map showing the location of current stem cell clinical trials.

Map of Stem Cell Clinical Trials, by Geographical Region

Map of Stem Cell Clinical Trials

“Hotspots” for Stem Cell Clinical Trial Activity

Clearly, North America (3057 trials) and Europe (1288 trials) are “hotspots” for stem cell clinical trial activity.

Among the North American trials, nearly all of them of them are occurring in the United States (2935).  [Read more…]

Boston Biolife to Host Stem Cell and Regenerative Medicine Workshops in Dallas, San Diego, and Washington, DC

By Leave a Comment

Boston BiolifeBoston BioLife (www.bostonbiolife.com) is a cutting-edge organization that provides workshops for physicians and scientists interested in learning regenerative medicine. Its mission is to facilitate the introduction of emerging life sciences technologies to scientists and healthcare providers. [Read more…]

Your ULTIMATE Guide to the FDA Public Hearing on “Draft Guidances” Regulating Cells and Tissues (Part 15)

By Leave a Comment

Nearly everyone in the stem cell community knows that there was supposed to be a FDA public hearing on April 13, 2016, related to four draft guidances controlling the regulation of stem cells.

Officially called a public hearing on “Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products Part 15,” the event was to be held at the FDA White Oak Campus located at 10903 New Hampshire Ave., Bldg. 31, Rm 1503 (Great Room), Silver Spring, MD, 20993.

To enroll for the event, you had to email “[email protected]” with your request to attend, contact information, and whether or not you wished to be a presenter. Whether it was intentional or not, very little time was given for the registration, which ended on on Jan. 8th, 2016, more than three months before the event was scheduled. [Read more…]

Key Market Leaders for Adipose-Derived Mesenchymal Stem Cell (MSC) Storage

By Leave a Comment

In addition to cord tissue storage, many cord blood banks are now investigating the addition of adipose-derived stem cell storage.

It is a logical product extension for cord blood banks, given that a range of collection, processing, and storage equipment is already present within the facility.

Additionally, conversion costs to allow for adipose-derived stem cell storage can be as low as USD $100,000 to $150,000.

The conversion of a cord blood facility to be able to offer adipose-derived stem cell storage can be efficiently accomplished through collaboration with a specialist in the area of adipose tissue extraction and storage.

Companies such as American Cryostem in the United States have been willing to partner with cord blood banks to assist them with adding adipose-derived MSC storage as a service.

Leading Companies Offering Mesenchymal Stem Cell (MSC) Storage

Below is an analysis of both diversified cord blood banks and specialty companies that currently offer adipose-derived stem cell storage. [Read more…]

BioInformant's World-Class Clients